VIENNA—Acupuncture treatments appear to relieve the common
musculoskeletal discomfort experienced by women taking aromatase inhibitors (AIs) to reduce the risk of recurrent breast cancer, researchers reported in a small, single-arm study.
Giovanni Giardina, MD, Senior Assistant in Oncology at Ospedale diCircolo e Fondazione Macchi reported that a study of Italian women with self-reported musculoskeletal pain, who were treated with acupuncture techniques, reported improvement in pain and quality of life on validated assessment instruments.
He and his coauthors enrolled 17 women in the study, and reported on outcomes for 16, all of whom were experiencing musculoskeletal pain as a result of long-term therapy with aromatase inhibitors. The women ranged in age from 49 to 78, with a median of 62.
“All patients had a significant improvement of musculoskeletal aromatase inhibitor-related pain,” Giardina reported, “and our study suggests that acupuncture may be a promising modality for relieving aromatase inhibitor-related musculoskeletal side effects.